Pathomics Health Pte Ltd Receives the Prestigious Singapore SME 500 Award
We are proud to announce that Pathomics Health Pte Ltd has been awarded the Singapore SME 500 Award, a recognition presented by the Association of Trade and Commerce (ATC) to honour Singapore’s top-performing small and medium enterprises. This award celebrates SMEs that have demonstrated business excellence, resilience, and consistent performance across key areas such as […]
Pathomics Health awarded Singapore SME 500 2025
We are proud to announce that Pathomics Health has passed all assessments by Association of Trade and Commerce (ATC) and have made it to the Singapore SME 500 Award 2025! The assessment involves evaluating enterprises in its business standards and qualities, including the ability to further develop the business and scale its market. The Singapore […]
Pathomics Health Partners with Health Deliver to Expand Access to Genetic Testing in Thailand
Pathomics Health is excited to announce our partnership with Health Deliver to commercialise our Pathgene products and services to customers in Thailand. The entire customer journey will be handled by Health Deliver to provide a holistic earlier insights, earlier intervention, better disease management, and improved health outcomes.
Inspire Healthcare to License Pathgene Neurological Series for Enhanced Patient Insights
Pathomics Health is excited to announce our partnership with Inspire Healthcare! Under the collaboration, Inspire Healthcare will license and commercialize our Pathgene Neurological series – DNA profiling for neurological diseases such as dementia, ADHD, Alzheimer’s, and Parkinson’s disease. Beyond commercialising, Inspire Healthcare will be integrating the DNA profiling outcome into their upcoming prognosis product, a […]
First overseas Joint Venture Company – PathoKBP Innovations LLC (Mongolia)
Pathomics Health is pleased to announce that our first overseas Joint Venture Company – PathoKBP Innovations LLC (Mongolia) has signed a Memorandum of Understanding (MOU) with Fourth Hospital (prestigious private hospital in Mongolia), a significant step toward advancing preventive healthcare solutions and clinical diagnostics. This partnership reflects a mutual commitment toward improving Mongolia healthcare to better […]
Launch of DNLite-DKD test in Singapore
Currently, urine Albuminuria-to-Creatinine Ratio (UACR) and estimation of GFR (eGFR) does not have the sensitivity and specificity for early prediction of diabetic kidney disease(DKD) in type 2 diabetic patient (T2DP). Thus, both UACR and eGFR are unfit for DKD management. Taken from: Nonalbuminuric vs albuminuric diabetic kidney disease in type 2 diabetes: A systematic review […]
Renewal of MOH License for Clinical Laboratory in Singapore
Pathomics Health is pleased to announce the successful renewal of its Ministry of Health license in Singapore, a key milestone in maintaining its commitment to high-quality medical testing and services. This renewal underscores the laboratory’s adherence to stringent health and safety regulations and its ongoing dedication to delivering reliable and accurate diagnostic results. This Ministry […]
Empowering a Healthier Future through Collaboration between Pathomics Health & AGTC Genomics
We are thrilled to announce a groundbreaking Memorandum of Understanding (MoU) between AGTC Genomics and Pathomics Health to enhance the accessibility and affordability of precision medicine in Malaysia and Southeast Asia.In an era of advancing medical breakthroughs, we stand at the forefront of a transformative partnership that holds the promise of reshaping healthcare as we […]
Pathomics Health Attains CAP Accreditation in Singapore
Pathomics Health is proud to announce that Pathomics Health Laboratory in Singapore has been accredited by the College of America Pathologists (CAP). This accreditation is a testament to Pathomics Health’s commitment to excellence in healthcare and dedication to providing our patients with the highest quality of care. We are grateful to the team for their […]
Launch of Clinical Laboratory Services in Singapore
Pathomics Health is pleased to introduce the following new tests effective 03 January 2023: EarlyCDT®-Lung QuantiFERON®-TB Gold Plus cPass™ SARS-CoV-2 Neutralization Antibodies Contact us at 6518 9233 or services@pathomicshealth.com for more information.